MBAM
IRD

Mink Brook Asset Management’s Opus Genetics IRD Stock Holding History

Mink Brook Asset Management’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$663K Sell
161,205
-429,347
-73% -$2M 0.29% 39
2026
Q1 		$2.69M Sell
590,552
-1,075,079
-65% -$3.72M 1.5% 16
2025
Q4 		$3.35M Buy
1,665,631
+427,684
+35% +$868K 2.12% 13
2025
Q3 		$2.04M Buy
1,237,947
+40,331
+3% +$50.1K 1.38% 17
2025
Q2 		$1.13M Buy
1,197,616
+387,536
+48% +$359K 0.98% 16
2025
Q1 		$795K Buy
+810,080
New +$905K 0.84% 19

Other funds holding IRD

CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Mink Brook Asset Management's IRD Position: Q2 2026 in Review

Mink Brook Asset Management reduced its Opus Genetics (IRD) stake by 73% in Q2 2026, selling an estimated $2M and leaving 161,205 shares worth $663K. The position accounts for 0.29% of the portfolio, ranked #39.

Mink Brook Asset Management first reported a position in IRD in Q1 2025 and has held it in 6 quarters since. The position peaked at $3.35M in Q4 2025. 103 funds tracked by Wall St. Rank hold IRD as of Q2 2026.

  • Mink Brook Asset Management held 161,205 shares of Opus Genetics worth $663K as of Q2 2026.
  • Mink Brook Asset Management sold 429,347 Opus Genetics shares in Q2 2026, an estimated $2M.
  • Opus Genetics made up 0.29% of Mink Brook Asset Management's portfolio in Q2 2026, its #39 holding.
  • Mink Brook Asset Management first reported a position in Opus Genetics in Q1 2025 and has held it in 6 quarters since.
  • Mink Brook Asset Management's Opus Genetics position peaked at $3.35M in Q4 2025.
  • 103 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2026.

Based on Mink Brook Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.